Ro 41-5253

Research use only, not for human use.

Ro 41-5253 is an orally active RARα antagonist, ligand, and partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ.

Ro 41-5253 is an orally active selective retinoic acid receptor alpha (RARα) antagonist. Ro 41-5253 can bind RARα without inducing transcription or affecting RAR/RXR heterodimerization and DNA binding. Ro 41-5253 can inhibit cancer cell proliferation and induce apoptosis, has antitumor activity.

Ro 41-5253 (1 nM-10 μM, 10 days) significantly inhibits MCF-7 and ZR 75.1 cell proliferation and induces cell apoptosis in a time and dose-dependent manner.Cell Proliferation Assay Cell Line:Human breast-carcinoma lines MCF-7 and ZR.Concentration:1 nM-10 μMIncubation Time:10 days Result:Inhibited 81% MCF-7 cell growth at 10 μM, 30% cell growth at 1 μM and no significant inhibitory effect at concentrations below 0.1 μM.Inhibited 74% ZR 75.1 cell growth at 10 μM, 63% cell growth at 1 μM and 42% cell growth at 0.1 μM.Apoptosis Analysis Cell Line:Human breast-carcinoma lines MCF-7 and ZR 75.1 Concentration:1 nM-10 μM Incubation Time:10 days Result:Induced 28.5, 21.6, 16 and 12% of MCF-7 cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively on the fourth day while induced 58, 51, 36 and 21% of cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively after six days.Induced 80, 65, 43 and 29% of ZR 75.1 cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively on the sixth day.

Ro 41-5253 (oral gavage, 10-600 mg/kg, once a week, 4 weeks) can reduce tumor volume in female athymic Balb/mice transplanted with MCF-7 cell line.Animal Model:Six-week-old female athymic Balb/mice transplanted with MCF-7 cell line Dosage:10, 30, 100, 300 and 600 mg/kg Administration:Oral gavage; once a week; 4 weeks Result:Resulted in a reduction in tumor volume at doses of 10, 30 and 100 mg/kg with no toxic side effects.

——

Metabolic Enzyme/Protease

Retinoid Receptor

Retinoid Receptor | Apoptosis

——

——

144092-31-9

484.65

C28H36O5S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (206.33 mM; Ultrasonic )

CCCCCCCOc1cc2c(cc1\C(C)=C\c1ccc(cc1)C(O)=O)C(C)(C)CCS2(=O)=O

——

(-20℃)

With Ice Pack

≥ 2 years